Merck Income Statement
View: Annual | Quarterly
| Dec 08 | Dec 07 | Dec 06 | |
|---|---|---|---|
| Revenue | 18,502.0 | 12,690.0 | 10,594.0 |
| Cost of Goods Sold | 7,307.0 | 4,405.0 | 3,697.0 |
| Gross Profit | 11,195.0 | 8,285.0 | 6,897.0 |
| Gross Profit Margin | 60.5% | 65.3% | 65.1% |
| SG&A Expense | 6,823.0 | 5,468.0 | 4,718.0 |
| Depreciation & Amortization | 2,175.0 | 861.0 | 568.0 |
| Operating Income | 2,585.0 | (970.0) | 1,655.0 |
| Operating Margin | 14.0% | -- | 15.6% |
| Nonoperating Income | 2,000.0 | (1,106.0) | 0.0 |
| Nonoperating Expenses | (465.0) | -- | -- |
| Income Before Taxes | 2,049.0 | (1,215.0) | 1,483.0 |
| Income Taxes | 146.0 | 258.0 | 362.0 |
| Net Income After Taxes | 1,903.0 | (1,473.0) | 1,121.0 |
| Continuing Operations | 1,903.0 | (1,473.0) | 1,121.0 |
| Discontinued Operations | -- | -- | -- |
| Total Operations | 1,903.0 | (1,473.0) | 1,121.0 |
| Total Net Income | 1,903.0 | (1,473.0) | 1,121.0 |
| Net Profit Margin | 10.3% | -- | 10.6% |
| Diluted EPS from Total Net Income ($) | 1.07 | (1.04) | 0.71 |
| Dividends per Share | 0.26 | 0.25 | 0.22 |
© 2009 Morningstar, Inc. Financial Data provided by
